Opaganib Promotes Weight Loss and Suppresses High-Fat Diet-Induced Obesity and Glucose Intolerance
Overall, the data indicate that opaganib effectively suppresses the loss of metabolic control in mice on HFD, suggesting that opaganib may be useful alone or in combination with existing therapies for weight management and improve conditions associated with obesity and diabetes.
Authors
- Lynn W. Maines
- Charles D. Smith (ORCID: https://orcid.org/0000-0001-7185-5928)
- Staci N. Keller
Institutions
- Apogee Biotechnology (United States) (US)
Publication Details
- Journal
- Diabetes Metabolic Syndrome and Obesity
- Published
- 2025-04-01
- DOI
- https://doi.org/10.2147/dmso.s514548
- Citations
- 2
- Primary Topic
- Diet and metabolism studies
- Type
- article
- Field-Weighted Citation Impact
- 2.33
Funders
- Pennsylvania Department of Health